Methylphenidate
Medically reviewed by Dr. Sofia Lindqvist, · Last reviewed 11 August 2026
On this page
How it works
Methylphenidate blocks the reuptake of dopamine and norepinephrine. Unlike amphetamines, it does not reverse transporter direction and does not trigger substantial release from vesicular stores.
That places it mechanistically between modafinil and amphetamine. It is a reuptake inhibitor like modafinil, but a considerably more potent one, with faster onset and greater abuse liability.
Reuptake blockade → transporter reversal
Approved uses
ADHD in children and adults.
Narcolepsy, as with amphetamines — the point of overlap with the wakefulness agents on this site.
Formulations
Immediate release (Ritalin)
0.5–4 h
Adderall XR
1–12 h
| Formulation | Duration | Practical consequence |
|---|---|---|
| Immediate release | 3–4 hours | Flexible, but requires redosing and produces a clearer end-of-dose dip |
| Extended release | 8–12 hours | One dose covers the school or working day, with less variability |
Scheduling and safety
Schedule II, the same as amphetamines. Common adverse effects include appetite suppression, insomnia, headache, raised heart rate and blood pressure, and irritability.
As with amphetamines, tapering rather than abrupt discontinuation is the common approach, given rebound and withdrawal concerns.